Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Journal of Molecular Biology|January 27, 2005
Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAsSteffen Schubert, Hans-Peter Grunert, Heinz Zeichhardt, et al.
FEBS Letters|August 12, 2008
Design of LNA-modified siRNAs against the highly structured 5' UTR of coxsackievirus B3Mariola Dutkiewicz, Hans-Peter Grunert, Heinz Zeichhardt, et al.
Nucleic Acids Research|October 8, 2003
RNA cleaving '10-23' DNAzymes with enhanced stability and activitySteffen Schubert, Deniz C Gül, Hans-Peter Grunert, et al.
Viruses|September 28, 2024
Combining RNA Interference and RIG-I Activation to Inhibit Hepatitis E Virus ReplicationMathias Ziersch, Dominik Harms, Lena Neumair, et al.
Journal of Visualized Experiments : Jove|November 3, 2016
Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2Thomas Hiller, Viola Röhrs, Eva-Maria Dehne, et al.
International Journal of Molecular Sciences|July 29, 2025
Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3Anja Geisler, Babette Dieringer, Leslie Elsner, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 9, 2004
Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cellsChristina Warnecke, Zaneta Zaborowska, Jens Kurreck, et al.
Human Gene Therapy|May 10, 2018
Heparan Sulfate Binding Coxsackievirus B3 Strain PD: A Novel Avirulent Oncolytic Agent Against Human Colorectal CarcinomaAhmet Hazini, Markian Pryshliak, Vanessa Brückner, et al.
Pageof 11